BackAmbrx Biopharma Overview

Ambrx Biopharma Selling, General & Admin

Selling, General & Admin expenses for AMAM.

Quarterly SG&A Expenses

$9.41M
↑ 50% YoY

As of Sep 30, 2023

Annual SG&A Expenses (TTM)

$28.90M
↑ 36.99% YoY

Trailing 12 months ending Sep 30, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin